Voisin Consulting Life Sciences

regulatory vcls healthcare pharmaceutical brexit medical devices registration medtech biotechnology drug eu atmp development usa market access richard dennett outsourcing technology transfer medicaldevice expedited programs drug development fda healthtech regulatory science medical device voisin consulting microbiome regulatory strategy clinical in vitro diagnostics clinical trials gene therapy medical framework odd orphan designation status raps hta europe early dialogue health technology assessment rare diseases launch approval optimization product development potency assay jean-hugues trouvin valérie pimpaneau françois gianelli anne dupraz poiseau strategy